Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001283303-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
2,994
Total Value
$96,358.61
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer and GC | Common Stock | โ | Feb 4, 2026 | Sale | 2,485 | $32.07 | $79,693.95 | 105,720 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Feb 4, 2026 | Sale | 509 | $32.74 | $16,664.66 | 105,211 | Direct | โ | View Details |